Health Canada
- Status: approved
Use of MEOPA during suturing (Use of MEOPA during suturing) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Centre Hospitalier Universitaire de Nīmes is the originator. The local marketing authorisation holder may differ — check the official source linked above.